Skip to main content


Fig. 1 | Journal of Experimental Orthopaedics

Fig. 1

From: Iodine contrast agents do not influence Platelet-Rich Plasma function at an early time point in vitro

Fig. 1

In Vitro quantitative assessment. aInitial PRP concentration in the samples (t = 0), in the presence of Visipaque270® and Iopamiron200®. b Evolution of PRP ratio as a function of time (5 incubation delays: 5, 10, 15, 20, 30mn), for each contrast agent group (Visipaque270® and Iopamiron200®). c Morphological aspect of platelets before and after exposure to iodine contrast agent: no change was seen

Back to article page